Oncology Drugs Approved by the FDA in January 2025 Darlene Dobkowski, MA February 4th 2025 Article January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies. Zipalertinib Achieves ORR Primary Endpoint in NSCLC Study ...
Insights on the Newly Approved Subcutaneous Infusion Therapy for Parkinson Disease Jonathan Rubin, MD, MBA;Isabella Ciccone, MPH February 7th 2025 Article Jonathan Rubin, MD, MBA, chief medical officer at Supernus Pharmaceuticals, talked about the recent approval of the company’s subcutaneous infusio...
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Volume 9, page 9, (2010) Cite this article Download PDF From View current issue Sign up to alerts We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact support so we can address the problem. Database of ...
CAT is responsible for preparing a draft opinion on the quality, safety and efficacy of each ATMP for final approval by the EMEA's Committee for Medicinal Products for Human Use. Rights and permissions Reprints and permissions About this article Cite this article News in brief. Nat Rev Drug ...
Sex&Drugs&Rock&Rol See full article at Deadline TV 7/17/2015 Deadline TV IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, ...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience. Abstract Obstetric diseases represent a highly complex medical challenge, especially regarding its clinical approach. The use of phar...
The latest news on cholesterol-lowering drugsDescribes results of two studies on the use of Mevaco, Merck & Co.'s brand name for cholesterol-lowering drug, lovastatin. Benefit to middle-aged people with normal or...
In the ongoing battle between bacteria and antibiotics, strains of Staphylococcus aureus are emerging the winners, reports Douglas Braaten.
Volume 11, page 259, (2012) Cite this article Download PDF From View current issue Sign up to alerts 813 Accesses 1 Altmetric Explore all metrics Drug wakes latent HIV in man Credit: GETTY Latent HIV pools can be awakened in humans using an HDAC inhibitor, shows a breakthrough study. ...